Delivery Order SPE2DB20D3104-SPE2DB21FV8P7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution to support the Defense Logistics Agency (DLA) Troop Support Medical. The $15,286.20 delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA, which runs through November 2026. This IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., covers the delivery of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $86,386.86 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA, which runs through December 2025. The contract includes a wide range of essential medical commodities such as specialty medications,...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) provides a prime vendor pharmaceutical distribution solution for the Defense Logistics Agency (DLA). The $9,639.02 delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which runs through November 2026. This IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, valued at $47,171.55, is a delivery order issued under an Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, worth up to $999,999,999.00 through November 2026. This IDC enables Cencora, Inc. to efficiently deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,156.36 delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA that runs through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to deliver a comprehensive range of essential medical commodities,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution services to support the Defense Logistics Agency (DLA) Troop Support Medical. The $1,492.80 delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,452.14 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that was awarded to Cencora, Inc. through the DLA Troop Support Medical program. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution in support of the Defense Logistics Agency (DLA) Troop Support Medical. The $8,432.68 delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, which runs through November 2026. This IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,930.00 delivery order falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA, which serves as the primary vehicle for the company to deliver essential medical commodities to support military healthcare programs...
- The federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution services to support the Defense Logistics Agency (DLA) Troop Support Medical. The $6,677.45 delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA that runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB21FV8P7Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution to support the Defense Logistics Agency (DLA) Troop Support Medical program. The $16,949.74 Delivery Order was issued under a $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, which runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, syringes, vials, and other critical care items, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries globally. The contract award does not have a set-aside designation, indicating it was competed on a full and open basis. In addition to the DLA IDC, Cencora, Inc. holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 7/2/21 |